DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,350,049 | +2.6% | 49,779 | -0.7% | 3.44% | +8.9% |
| Q2 2023 | $12,035,403 | -5.7% | 50,148 | -1.0% | 3.16% | -11.9% |
| Q1 2023 | $12,768,475 | -6.1% | 50,661 | -1.1% | 3.58% | -11.5% |
| Q4 2022 | $13,596,740 | +5.1% | 51,227 | -0.3% | 4.05% | +0.5% |
| Q3 2022 | $12,937,000 | -0.7% | 51,405 | +0.0% | 4.03% | -5.0% |
| Q2 2022 | $13,030,000 | +0.8% | 51,397 | -0.4% | 4.24% | +12.2% |
| Q1 2022 | $12,930,000 | -25.9% | 51,614 | -2.6% | 3.78% | -8.5% |
| Q4 2021 | $17,438,000 | +6.4% | 53,001 | -1.6% | 4.14% | -1.1% |
| Q3 2021 | $16,394,000 | +12.1% | 53,850 | -1.2% | 4.18% | +11.6% |
| Q2 2021 | $14,628,000 | +19.6% | 54,509 | +0.3% | 3.75% | +11.1% |
| Q1 2021 | $12,227,000 | +1.6% | 54,325 | +0.3% | 3.37% | -4.7% |
| Q4 2020 | $12,030,000 | -4.9% | 54,155 | -7.8% | 3.54% | -15.9% |
| Q3 2020 | $12,648,000 | +20.8% | 58,738 | -0.8% | 4.21% | +9.1% |
| Q2 2020 | $10,467,000 | +12.3% | 59,193 | -12.1% | 3.86% | -12.4% |
| Q1 2020 | $9,322,000 | -9.3% | 67,351 | +0.6% | 4.40% | +20.2% |
| Q4 2019 | $10,276,000 | +6.2% | 66,952 | -0.0% | 3.66% | -1.9% |
| Q3 2019 | $9,673,000 | -2.7% | 66,974 | -3.7% | 3.73% | +0.7% |
| Q2 2019 | $9,939,000 | +6.8% | 69,544 | -1.4% | 3.71% | -2.3% |
| Q1 2019 | $9,310,000 | +25.8% | 70,517 | -1.8% | 3.80% | +7.0% |
| Q4 2018 | $7,403,000 | -8.2% | 71,787 | -3.2% | 3.55% | +14.2% |
| Q3 2018 | $8,061,000 | +10.2% | 74,184 | +0.1% | 3.10% | +5.7% |
| Q2 2018 | $7,312,000 | +1.5% | 74,099 | +0.7% | 2.94% | +0.8% |
| Q1 2018 | $7,204,000 | +6.2% | 73,574 | +0.7% | 2.91% | +7.7% |
| Q4 2017 | $6,782,000 | +8.2% | 73,065 | -0.0% | 2.70% | +3.0% |
| Q3 2017 | $6,268,000 | -2.9% | 73,073 | -4.5% | 2.63% | -7.2% |
| Q2 2017 | $6,456,000 | -2.3% | 76,503 | -1.0% | 2.83% | -3.4% |
| Q1 2017 | $6,610,000 | +8.8% | 77,287 | -1.0% | 2.93% | +2.2% |
| Q4 2016 | $6,075,000 | -1.7% | 78,047 | -1.0% | 2.87% | -3.3% |
| Q3 2016 | $6,181,000 | -22.6% | 78,852 | -0.3% | 2.96% | -25.2% |
| Q2 2016 | $7,988,000 | +7.8% | 79,085 | +1.3% | 3.96% | +6.4% |
| Q1 2016 | $7,408,000 | +0.7% | 78,090 | -1.5% | 3.73% | +4.1% |
| Q4 2015 | $7,360,000 | +11.5% | 79,244 | +2.3% | 3.58% | +4.3% |
| Q3 2015 | $6,599,000 | -2.6% | 77,439 | -2.2% | 3.43% | +8.2% |
| Q2 2015 | $6,775,000 | +0.9% | 79,155 | +0.1% | 3.17% | +2.3% |
| Q1 2015 | $6,715,000 | -0.3% | 79,094 | +0.6% | 3.10% | -2.5% |
| Q4 2014 | $6,737,000 | +16.8% | 78,600 | +3.5% | 3.18% | +14.5% |
| Q3 2014 | $5,767,000 | -4.6% | 75,906 | -1.2% | 2.78% | -5.5% |
| Q2 2014 | $6,048,000 | +6.0% | 76,821 | +0.9% | 2.94% | +1.4% |
| Q1 2014 | $5,708,000 | -1.8% | 76,101 | +1.1% | 2.90% | -1.9% |
| Q4 2013 | $5,813,000 | +16.6% | 75,301 | +4.7% | 2.95% | +6.7% |
| Q3 2013 | $4,985,000 | +8.3% | 71,914 | -1.1% | 2.77% | +5.7% |
| Q2 2013 | $4,605,000 | – | 72,749 | – | 2.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |